Lan Ding is a portfolio management and analytics leader driving data-powered decision optimization for GSK's R&D pipeline investments. With over 10 years experience and EMBA, Lan has spearheaded analytics platforms leveraging cutting-edge frameworks and industry best practices to optimize high-stakes portfolios. Recognised for bridging the gap between data insights and actions, Lan’s pioneering frameworks have delivered lasting impact, including revamped Probability of Regulatory Success valuation process at GSK. At SDP Conference, she will share her wealth of expertise enabling analytics-based transformation and investment optimization within complex pharmaceutical pipelines.